Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Milton B. Dobkin"'
Concern for virus transmission from intravenous biological products, derived from natural and biotechnological sources, has prompted us to investigate various methods for virus inactivation while preserving the biological activity of the therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b398838da5df892daf5b8a310e1c4a5a
https://doi.org/10.1159/000416555
https://doi.org/10.1159/000416555
Publikováno v:
Vox Sanguinis. 65:81-86
An IgM concentrate was purified from Cohn fraction III. Efficiency of euglobin precipitation was shown to be controlled by pH and ionic strength. Prekallikrein activator activity in the product was insignificant. Overall yield from the octanoic acid
Publikováno v:
Biologicals. 19:177-185
Manufacturing processes for therapeutic products derived from recombinant DNA and hybridoma technology have required a re-assessment of the parameters traditionally applied for inactivation of endogenous viruses. Historically, time, temperature and c
Publikováno v:
Vox Sanguinis. 67:80-82
Publikováno v:
American Journal of Clinical Pathology. 99:649-649
Autor:
Sharon G. Paryani, Celine M. Koropchak, Alec E. Wittek, Miriam D. Budinger, Ann M. Arvin, Michael D. Amylon, Milton B. Dobkin
Publikováno v:
The American journal of medicine. 76(3A)
Varicella is a serious infection in the immunocompromised patient. Prophylaxis with varicella zoster immune globulin is known to decrease the incidence of severe varicella infection. The titers of antibody to varicella zoster virus were compared in p
Publikováno v:
The American journal of medicine. 84(6A)
Alpha-1-proteinase inhibitor concentrates have been prepared from pooled human plasma for therapeutic applications. Pasteurization (60 degrees C, 10 hours) conditions have been defined to reduce risks of transmission of viral agents without significa
Autor:
Paul K. Ng, Milton B. Dobkin
Publikováno v:
Thrombosis research. 39(4)
Heating sterilized albumin preparations at 600 degrees C for 10 hours has historically been shown to yield a hepatitis-free, efficacious product. We have evaluated such a pasteurization procedure with AHF preparations. Procoagulant activity and fibri